{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:55:27Z","timestamp":1791618927480,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82201954 to Z.R."],"award-info":[{"award-number":["82201954 to Z.R."]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03659-8","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T14:50:26Z","timestamp":1739458226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Potential predictive role of Non-HDL to HDL Cholesterol Ratio (NHHR) in MASLD: focus on obese and type 2 diabetic populations"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiao-Man","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Miao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Guang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"3659_CR1","doi-asserted-by":"publisher","unstructured":"Malhi, H. et al. Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals. Hepatology (Baltimore, Md.)\u00a02023;78, 1680\u20131681, https:\/\/doi.org\/10.1097\/hep.0000000000000619.","DOI":"10.1097\/hep.0000000000000619"},{"key":"3659_CR2","doi-asserted-by":"publisher","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology (Baltimore, Md.)\u00a02023;78, 1966\u20131986, https:\/\/doi.org\/10.1097\/hep.0000000000000520.","DOI":"10.1097\/hep.0000000000000520"},{"key":"3659_CR3","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73:202\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039.","journal-title":"J Hepatol"},{"key":"3659_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3659_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","volume":"26","author":"N Stefan","year":"2017","unstructured":"Stefan N, Schick F, H\u00e4ring HU. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab. 2017;26:292\u2013300. https:\/\/doi.org\/10.1016\/j.cmet.2017.07.008.","journal-title":"Cell Metab"},{"key":"3659_CR6","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/liv.14828","volume":"41","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Perseghin G. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver international\u202f: official journal of the International Association for the Study of the Liver. 2021;41:1290\u20133. https:\/\/doi.org\/10.1111\/liv.14828.","journal-title":"Liver international : official journal of the International Association for the Study of the Liver"},{"key":"3659_CR7","doi-asserted-by":"publisher","unstructured":"Younossi, Z. M., Otgonsuren, M., Venkatesan, C. & Mishra, A. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. Metabolism: clinical and experimental.\u00a02013;62, 352\u2013360, https:\/\/doi.org\/10.1016\/j.metabol.2012.08.005.","DOI":"10.1016\/j.metabol.2012.08.005"},{"key":"3659_CR8","doi-asserted-by":"publisher","unstructured":"Chalasani, N. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.)\u00a02018;67, 328\u2013357, https:\/\/doi.org\/10.1002\/hep.29367.","DOI":"10.1002\/hep.29367"},{"key":"3659_CR9","doi-asserted-by":"publisher","unstructured":"Younossi, Z. et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.)\u00a02019;69, 2672\u20132682, https:\/\/doi.org\/10.1002\/hep.30251.","DOI":"10.1002\/hep.30251"},{"key":"3659_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.03.006","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, et al. The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes. Clinical gastroenterology and hepatology\u202f: the official clinical practice journal of the American Gastroenterological Association. 2024. https:\/\/doi.org\/10.1016\/j.cgh.2024.03.006.","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association"},{"key":"3659_CR11","doi-asserted-by":"publisher","unstructured":"Qi, X., Li, J., Caussy, C., Teng, G. J. & Loomba, R. Epidemiology, screening, and Co-management of type 2 diabetes mellitus and Metabolic-dysfunction associated steatotic liver disease. Hepatology (Baltimore, Md.). 2024.\u00a0https:\/\/doi.org\/10.1097\/hep.0000000000000913.","DOI":"10.1097\/hep.0000000000000913"},{"key":"3659_CR12","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13098-021-00741-5","volume":"13","author":"S Karami","year":"2021","unstructured":"Karami S, et al. Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease. Diabetol Metab Syndr. 2021;13:121. https:\/\/doi.org\/10.1186\/s13098-021-00741-5.","journal-title":"Diabetol Metab Syndr"},{"key":"3659_CR13","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2337\/dc07-1088","volume":"30","author":"AM Cali","year":"2007","unstructured":"Cali AM, et al. Intrahepatic fat accumulation and alterations in lipoprotein composition in obese adolescents: a perfect proatherogenic state. Diabetes Care. 2007;30:3093\u20138. https:\/\/doi.org\/10.2337\/dc07-1088.","journal-title":"Diabetes Care"},{"key":"3659_CR14","doi-asserted-by":"publisher","unstructured":"Fujita, K. et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology (Baltimore, Md.)\u00a02009;50, 772\u2013780, https:\/\/doi.org\/10.1002\/hep.23094.","DOI":"10.1002\/hep.23094"},{"key":"3659_CR15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","volume":"119","author":"C Grander","year":"2023","unstructured":"Grander C, Grabherr F, Tilg H. Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options. Cardiovasc Res. 2023;119:1787\u201398. https:\/\/doi.org\/10.1093\/cvr\/cvad095.","journal-title":"Cardiovasc Res"},{"key":"3659_CR16","doi-asserted-by":"publisher","unstructured":"Wen, J. et al. Lipoprotein ratios are better than conventional lipid parameters in predicting arterial stiffness in young men. Journal of clinical hypertension (Greenwich, Conn.)\u00a02017;19, 771\u2013776, https:\/\/doi.org\/10.1111\/jch.13038.","DOI":"10.1111\/jch.13038"},{"key":"3659_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12944-020-01336-1","volume":"19","author":"WS Yang","year":"2020","unstructured":"Yang WS, et al. Importance of lipid ratios for predicting intracranial atherosclerotic stenosis. Lipids Health Dis. 2020;19:160. https:\/\/doi.org\/10.1186\/s12944-020-01336-1.","journal-title":"Lipids Health Dis"},{"key":"3659_CR18","doi-asserted-by":"publisher","first-page":"931","DOI":"10.5603\/KP.a2015.0086","volume":"73","author":"L Zhu","year":"2015","unstructured":"Zhu L, et al. Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people. Kardiol Pol. 2015;73:931\u20138. https:\/\/doi.org\/10.5603\/KP.a2015.0086.","journal-title":"Kardiol Pol"},{"key":"3659_CR19","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1016\/j.ijcard.2013.03.027","volume":"168","author":"SW Kim","year":"2013","unstructured":"Kim SW, et al. Non-HDL-cholesterol\/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B\/apolipoprotein A1. Int J Cardiol. 2013;168:2678\u201383. https:\/\/doi.org\/10.1016\/j.ijcard.2013.03.027.","journal-title":"Int J Cardiol"},{"key":"3659_CR20","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.2147\/dmso.S355980","volume":"15","author":"G Sheng","year":"2022","unstructured":"Sheng G, et al. Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk. Diabetes, metabolic syndrome and obesity\u202f: targets and therapy. 2022;15:1677\u201386. https:\/\/doi.org\/10.2147\/dmso.S355980.","journal-title":"Diabetes, metabolic syndrome and obesity : targets and therapy"},{"key":"3659_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2215\/cjn.03390807","volume":"3","author":"IH de Boer","year":"2008","unstructured":"de Boer IH, et al. Lipoprotein abnormalities associated with mild impairment of kidney function in the multi-ethnic study of atherosclerosis. Clinical journal of the American Society of Nephrology\u202f: CJASN. 2008;3:125\u201332. https:\/\/doi.org\/10.2215\/cjn.03390807.","journal-title":"Clinical journal of the American Society of Nephrology : CJASN"},{"key":"3659_CR22","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.numecd.2015.03.003","volume":"25","author":"PY Zuo","year":"2015","unstructured":"Zuo PY, et al. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease. Nutr Metab Cardiovasc Dis. 2015;25:582\u20137. https:\/\/doi.org\/10.1016\/j.numecd.2015.03.003.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"3659_CR23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022\u201330. https:\/\/doi.org\/10.1016\/j.jhep.2016.12.022.","journal-title":"J Hepatol"},{"key":"3659_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cgh.2020.06.048","volume":"19","author":"S Ciardullo","year":"2021","unstructured":"Ciardullo S, Monti T, Perseghin G. Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017\u20132018 National Health and Nutrition Examination Survey. Clinical gastroenterology and hepatology\u202f: the official clinical practice journal of the American Gastroenterological Association. 2021;19:384\u2013390.e381. https:\/\/doi.org\/10.1016\/j.cgh.2020.06.048.","journal-title":"Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association"},{"key":"3659_CR25","doi-asserted-by":"publisher","unstructured":"Xi, W. F. & Yang, A. M. Association between cardiometabolic index and controlled attenuation parameter in U.S. adults with NAFLD: findings from NHANES (2017\u20132020). Lipids in health and disease.\u00a02024;23, 40, https:\/\/doi.org\/10.1186\/s12944-024-02027-x.","DOI":"10.1186\/s12944-024-02027-x"},{"key":"3659_CR26","doi-asserted-by":"publisher","first-page":"e0252164","DOI":"10.1371\/journal.pone.0252164","volume":"16","author":"X Zhang","year":"2021","unstructured":"Zhang X, Heredia NI, Balakrishnan M, Thrift AP. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017\u20132018. PLoS ONE. 2021;16: e0252164. https:\/\/doi.org\/10.1371\/journal.pone.0252164.","journal-title":"PLoS ONE"},{"key":"3659_CR27","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","volume":"50","author":"G Marchesini","year":"2001","unstructured":"Marchesini G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844\u201350. https:\/\/doi.org\/10.2337\/diabetes.50.8.1844.","journal-title":"Diabetes"},{"key":"3659_CR28","first-page":"2569","volume":"13","author":"S Gao","year":"2020","unstructured":"Gao S, Ramen K, Yu S, Luo J. Higher non-HDL-cholesterol to HDL-cholesterol ratio is linked to increase in non-alcoholic fatty liver disease: secondary analysis based on a longitudinal study. Int J Clin Exp Pathol. 2020;13:2569\u201375.","journal-title":"Int J Clin Exp Pathol"},{"key":"3659_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12944-018-0720-x","volume":"17","author":"D Wang","year":"2018","unstructured":"Wang D, et al. Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis. Lipids Health Dis. 2018;17:67. https:\/\/doi.org\/10.1186\/s12944-018-0720-x.","journal-title":"Lipids Health Dis"},{"key":"3659_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12944-021-01457-1","volume":"20","author":"Y Zou","year":"2021","unstructured":"Zou Y, et al. LDL\/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study. Lipids Health Dis. 2021;20:28. https:\/\/doi.org\/10.1186\/s12944-021-01457-1.","journal-title":"Lipids Health Dis"},{"key":"3659_CR31","doi-asserted-by":"publisher","first-page":"1457589","DOI":"10.3389\/fendo.2024.1457589","volume":"15","author":"Y Xuan","year":"2024","unstructured":"Xuan Y, et al. Elevated non-HDL-C to HDL-C ratio as a marker for NAFLD and liver fibrosis risk: a cross-sectional analysis. Front Endocrinol. 2024;15:1457589. https:\/\/doi.org\/10.3389\/fendo.2024.1457589.","journal-title":"Front Endocrinol"},{"key":"3659_CR32","doi-asserted-by":"publisher","unstructured":"Speliotes, E. K. et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (Baltimore, Md.)\u00a02010;51, 1979\u20131987, https:\/\/doi.org\/10.1002\/hep.23593.","DOI":"10.1002\/hep.23593"},{"key":"3659_CR33","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1067\/mnc.2002.128959","volume":"9","author":"TN Tulenko","year":"2002","unstructured":"Tulenko TN, Sumner AE. The physiology of lipoproteins. Journal of nuclear cardiology\u202f: official publication of the American Society of Nuclear Cardiology. 2002;9:638\u201349. https:\/\/doi.org\/10.1067\/mnc.2002.128959.","journal-title":"Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology"},{"key":"3659_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0021-9150(99)00166-5","volume":"147","author":"Y Toyota","year":"1999","unstructured":"Toyota Y, Yamamura T, Miyake Y, Yamamoto A. Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia. Atherosclerosis. 1999;147:77\u201386. https:\/\/doi.org\/10.1016\/s0021-9150(99)00166-5.","journal-title":"Atherosclerosis"},{"key":"3659_CR35","doi-asserted-by":"publisher","unstructured":"Fon Tacer, K., Pompon, D. & Rozman, D. Adaptation of cholesterol synthesis to fasting and TNF-alpha: profiling cholesterol intermediates in the liver, brain, and testis. The Journal of steroid biochemistry and molecular biology.\u00a02010;121, 619\u2013625, https:\/\/doi.org\/10.1016\/j.jsbmb.2010.02.026.","DOI":"10.1016\/j.jsbmb.2010.02.026"},{"key":"3659_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12944-021-01573-y","volume":"20","author":"Y Zou","year":"2021","unstructured":"Zou Y, et al. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study. Lipids Health Dis. 2021;20:139. https:\/\/doi.org\/10.1186\/s12944-021-01573-y.","journal-title":"Lipids Health Dis"},{"key":"3659_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s00535-010-0203-y","volume":"45","author":"Y Kimura","year":"2010","unstructured":"Kimura Y, et al. Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. J Gastroenterol. 2010;45:750\u20137. https:\/\/doi.org\/10.1007\/s00535-010-0203-y.","journal-title":"J Gastroenterol"},{"key":"3659_CR38","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/jgh.12996","volume":"30","author":"Y Ha","year":"2015","unstructured":"Ha Y, et al. Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: A case-control study. J Gastroenterol Hepatol. 2015;30:1666\u201372. https:\/\/doi.org\/10.1111\/jgh.12996.","journal-title":"J Gastroenterol Hepatol"},{"key":"3659_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2036.2011.04929.x","volume":"35","author":"S Petta","year":"2012","unstructured":"Petta S, et al. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012;35:238\u201347. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04929.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"3659_CR40","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1111\/jgh.15595","volume":"36","author":"MS Kuchay","year":"2021","unstructured":"Kuchay MS, et al. Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2021;36:3204\u201311. https:\/\/doi.org\/10.1111\/jgh.15595.","journal-title":"J Gastroenterol Hepatol"},{"key":"3659_CR41","doi-asserted-by":"publisher","unstructured":"Jaiswal, M., Schinske, A. & Pop-Busui, R. Lipids and lipid management in diabetes. Best practice & research. Clinical endocrinology & metabolism.\u00a02014;28, 325\u2013338, https:\/\/doi.org\/10.1016\/j.beem.2013.12.001.","DOI":"10.1016\/j.beem.2013.12.001"},{"key":"3659_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0021-9150(00)00711-5","volume":"157","author":"M Zoltowska","year":"2001","unstructured":"Zoltowska M, et al. Circulating lipoproteins and hepatic sterol metabolism in Psammomys obesus prone to obesity, hyperglycemia and hyperinsulinemia. Atherosclerosis. 2001;157:85\u201396. https:\/\/doi.org\/10.1016\/s0021-9150(00)00711-5.","journal-title":"Atherosclerosis"},{"key":"3659_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/bj20020430","volume":"366","author":"F Foufelle","year":"2002","unstructured":"Foufelle F, Ferr\u00e9 P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J. 2002;366:377\u201391. https:\/\/doi.org\/10.1042\/bj20020430.","journal-title":"Biochem J"},{"key":"3659_CR44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12944-020-01322-7","volume":"19","author":"X Zhao","year":"2020","unstructured":"Zhao X, et al. Association between the non-HDL-cholesterol-to-HDL-cholesterol ratio and the risk of gallbladder polyp formation among men: a retrospective cohort study. Lipids Health Dis. 2020;19:146. https:\/\/doi.org\/10.1186\/s12944-020-01322-7.","journal-title":"Lipids Health Dis"},{"key":"3659_CR45","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.2337\/dc11-0209","volume":"34","author":"B Eliasson","year":"2011","unstructured":"Eliasson B, et al. Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register. Diabetes Care. 2011;34:2095\u2013100. https:\/\/doi.org\/10.2337\/dc11-0209.","journal-title":"Diabetes Care"},{"key":"3659_CR46","doi-asserted-by":"publisher","unstructured":"Kwok, R. M., Torres, D. M. & Harrison, S. A. Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? Hepatology (Baltimore, Md.) 2013;58, 1166\u20131174, https:\/\/doi.org\/10.1002\/hep.26390.","DOI":"10.1002\/hep.26390"},{"key":"3659_CR47","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.clnu.2017.06.018","volume":"37","author":"D Lin","year":"2018","unstructured":"Lin D, et al. Associations of lipid parameters with insulin resistance and diabetes: A population-based study. Clinical nutrition (Edinburgh, Scotland). 2018;37:1423\u20139. https:\/\/doi.org\/10.1016\/j.clnu.2017.06.018.","journal-title":"Clinical nutrition (Edinburgh, Scotland)"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03659-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03659-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T14:50:29Z","timestamp":1739458229000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03659-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03659-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The survey protocol for the NHANES received approval from the Institutional Research Ethics Review Board of CDC's National Center for Health Statistics. All participants gave written informed consent, and the NCHS Research Ethics Review Board also approved the study ().","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}